1. Home
  2. IRWD vs KE Comparison

IRWD vs KE Comparison

Compare IRWD & KE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

N/A

Current Price

$3.76

Market Cap

687.4M

Sector

Health Care

ML Signal

N/A

Logo Kimball Electronics Inc.

KE

Kimball Electronics Inc.

N/A

Current Price

$28.14

Market Cap

564.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
IRWD
KE
Founded
1998
1961
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electrical Products
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
687.4M
564.2M
IPO Year
2009
2014

Fundamental Metrics

Financial Performance
Metric
IRWD
KE
Price
$3.76
$28.14
Analyst Decision
Buy
Buy
Analyst Count
4
4
Target Price
$6.10
★ $34.25
AVG Volume (30 Days)
★ 1.5M
140.1K
Earning Date
11-09-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1400.00
66.18
EPS
0.55
★ 1.13
Revenue
$298,276,000.00
★ $1,431,378,000.00
Revenue This Year
$59.19
$7.92
Revenue Next Year
$4.80
$4.15
P/E Ratio
★ $7.49
$24.57
Revenue Growth
★ 8.88
N/A
52 Week Low
$1.41
$21.60
52 Week High
$5.78
$32.00

Technical Indicators

Market Signals
Indicator
IRWD
KE
Relative Strength Index (RSI) 40.20 62.40
Support Level $3.89 $23.59
Resistance Level $3.96 $28.00
Average True Range (ATR) 0.19 0.90
MACD -0.04 0.22
Stochastic Oscillator 7.28 78.18

Price Performance

Historical Comparison
IRWD
KE

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

Share on Social Networks: